TEDH

Stabil13 Meldungen9 QuellenZuletzt aktualisiert: 1 g önce

Neueste Meldungen

Luigi Mangione's Federal Trial in UnitedHealthcare CEO Killing Postponed to January

Luigi Mangione's federal trial for the killing of UnitedHealthcare CEO Brian Thompson has been postponed to January 2025, allowing his lawyers to focus on his state murder trial scheduled for September. Mangione, who pleaded not guilty, faces federal charges for traveling across state lines to stalk and kill Thompson, and has publicly criticized the prospect of two trials as "double jeopardy."

The Independent World

Plea Deal Talks Collapse for Man Accused of Killing UnitedHealthcare CEO

In Entwicklung

Crime·6 g önceKI-Zusammenfassung

Plea Deal Talks Collapse for Man Accused of Killing UnitedHealthcare CEO

Plea deal discussions between federal prosecutors and lawyers for Luigi Mangione, accused of killing UnitedHealthcare CEO Brian Thompson, have collapsed. Mangione, who pleaded not guilty to state and federal charges, faces trials in September and October, with the case sparking national debate on the U.S. health insurance system.

The Independent World

El TEDH no admite la demanda sobre inmersión lingüística en Canet de Mar

In Entwicklung

Politik·18.06.2026KI-Zusammenfassung

El TEDH no admite la demanda sobre inmersión lingüística en Canet de Mar

El Tribunal Europeo de Derechos Humanos (TEDH) no ha admitido a trámite una demanda sobre inmersión lingüística en Canet de Mar, alegando el derecho a ser educado en castellano como lengua nacional en un territorio bilingüe.

La Vanguardia

Mangione to use psychiatric defense in state murder trial

In Entwicklung

Crime·17.06.2026KI-Zusammenfassung

Mangione to use psychiatric defense in state murder trial

Luigi Mangione plans to use an extreme emotional disturbance defense in his state murder trial for the killing of UnitedHealthcare CEO Brian Thompson. This defense could lead to a manslaughter conviction instead of murder, potentially reducing his prison sentence. A federal case against Mangione is separate and does not allow this defense.

Euronews News

Luigi Mangione's defense to argue psychiatric defense in Brian Thompson murder trial

In Entwicklung

Crime·17.06.2026KI-Zusammenfassung

Luigi Mangione's defense to argue psychiatric defense in Brian Thompson murder trial

Luigi Mangione's lawyers will argue a psychiatric defense in his state murder trial for the shooting death of UnitedHealthcare CEO Brian Thompson. Judge Gregory Carro will unseal court records related to the defense's plan, which aims to show Mangione suffered "extreme emotional disturbance" at the time of the incident.

BBC World

Luigi Mangione Murder Hearing Delayed Due to Prosecutor Error

In Entwicklung

Crime·16.06.2026KI-Zusammenfassung

Luigi Mangione Murder Hearing Delayed Due to Prosecutor Error

A court hearing for Luigi Mangione, accused of killing UnitedHealthcare CEO Brian Thompson, was delayed Tuesday because prosecutors failed to notify jail officials of his required transport. The hearing is rescheduled for Wednesday.

The Independent World

Australian Housing Market Sees Price Stagnation and Declines

In Entwicklung

Business·02.06.2026KI-Zusammenfassung

Australian Housing Market Sees Price Stagnation and Declines

Australian house prices stagnated last month, with Sydney and Melbourne seeing price drops. This shift, driven by interest rate hikes, contrasts with the public and political view of housing as an investment rather than a basic need, hindering affordability efforts.

Guardian Australia

Fiscales recurren ante el TEDH el fallo del Constitucional sobre los 'dedazos'

In Entwicklung

Law·25.05.2026KI-Zusammenfassung

Fiscales recurren ante el TEDH el fallo del Constitucional sobre los 'dedazos'

La Asociación de Fiscales y el fiscal José Miguel de la Rosa han recurrido ante el Tribunal Europeo de Derechos Humanos (TEDH) la decisión del Tribunal Constitucional que permite los nombramientos discrecionales ('dedazos') en la cúpula fiscal, ignorando mérito y capacidad.

El Mundo

UnitedHealth Group Incorporated (NYSE:UNH) is included among the 10 High Quality Stocks to Buy According to Hedge Funds

NACHRICHT

22.05.2026KI-Zusammenfassung

UnitedHealth Group Incorporated (NYSE:UNH) is included among the 10 High Quality Stocks to Buy According to Hedge Funds

UnitedHealth Group (UNH) receives bullish analyst upgrades from UBS and BofA, with price targets raised to $460 and $420 respectively, driven by strong Q1 results and confidence in margin recovery.

Yahoo Finance

New York City Reviews Press Credentialing After 'Mangionistas' Controversy

In Entwicklung

Politik·21.05.2026KI-Zusammenfassung

New York City Reviews Press Credentialing After 'Mangionistas' Controversy

New York City is reviewing its press credentialing process after three supporters of accused murderer Luigi Mangione, known as 'The Mangionistas,' were issued press passes and made controversial public remarks. Mayor Zohran Mamdani stated they should not have received passes, highlighting the difficulty in distinguishing legitimate journalists from influencers and activists.

The Verge

NY Judge Blocks Evidence in Mangione Murder Trial

NACHRICHT

18.05.2026KI-Zusammenfassung

NY Judge Blocks Evidence in Mangione Murder Trial

A New York judge has blocked prosecutors from using evidence found in Luigi Mangione's backpack during his murder trial, ruling it was not sufficiently in his control when detained. Items like a magazine, cellphone, passport, wallet, and computer chip were suppressed, though a journal can be used.

CNBC

NACHRICHT

04.05.2026

How to buy a major Dow component, at a discount

UnitedHealth is one of the largest U.S. companies in one of the largest sectors that pays a respectable dividend. Mike Khouw still wouldn't buy the stock outright.

CNBC

UnitedHealth Posts Strong Q1 Earnings, Raises 2026 Profit Outlook

NACHRICHT

21.04.2026KI-Zusammenfassung

UnitedHealth Posts Strong Q1 Earnings, Raises 2026 Profit Outlook

UnitedHealth Group reported Q1 earnings of $7.23 per share, beating estimates of $6.57, with revenue of $111.72B. The company raised its 2026 profit outlook to over $18.25 per share, citing improved medical cost management and operational streamlining.

CNBC